Vivian Lewis Blog | Sunday Update: Merck Et Al | TalkMarkets
Editor and founder of Global-Investing.com
Contributor's Links: Global Investing
Vivian Lewis is editor and founder of Global-Investing.com, the daily blog newsletter for Americans and others seeking to internationalize their portfolios. She brings unique experience and competence to the business of picking foreign stocks. After graduating from Harvard magna cum laude (and ...more

Sunday Update: Merck Et Al

Date: Sunday, October 3, 2021 12:40 PM EDT

The Merck (MRK) pill regimen looks like a solution to protecting people from [the worst of] Covid-19. But there will still be need for other medicines as well. While Merck stock has soared 7.8% in one day after the news, the plunge in prices of alternative treatments like Moderna, Novavax, and BioNTech has been excessive, because the Merck pill will not be available for everyone to take for months at best.

Our best performer last week was Merck, up 10.6% but a close second was Cabot Oil, COG, up 9.4% and  Energy Fuels, UUUU, up 8.1%. Healthcare shares fell, even ones with little involvement with Covid-19 because they got ahead of themselves.

Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.